MDB Capital Holdings Reports Progress on Portfolio Expansion and Upcoming Offerings

Reuters
Nov 21, 2025
MDB Capital Holdings Reports Progress on Portfolio Expansion and Upcoming Offerings

MDB Capital Holdings LLC $(MDBH)$ provided an operational update for the third quarter ended September 30, 2025. The company announced it anticipates closing two offerings shortly: a $16.8 million private placement for Paulex Bio, a biopharmaceutical company focused on novel therapeutics for diabetes, and a $20 million IPO for Buda Juice, which specializes in UltraFresh™ cold-crafted juices, expected in December 2025. MDB Capital Holdings also reported expanded relationships with Registered Investment Advisors (RIAs) to reach new investors seeking alternative investment strategies, and welcomed TCA Venture Group and Keiretsu Forum MST angel group investors into its latest offerings. The company continues to improve the efficiency of its public venture platform and has expanded its pipeline of early-stage, disruptive companies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MDB Capital Holdings LLC published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9579851-en) on November 20, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10